|
NOTCH2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.057600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.599600E-01 |
| Normal-vs-Stage2 |
5.713900E-02 |
| Normal-vs-Stage3 |
2.718600E-01 |
| Normal-vs-Stage4 |
2.378800E-01 |
| Stage1-vs-Stage2 |
2.832000E-02 |
| Stage1-vs-Stage3 |
1.429590E-01 |
| Stage1-vs-Stage4 |
1.385980E-01 |
| Stage2-vs-Stage3 |
3.534800E-01 |
| Stage2-vs-Stage4 |
4.313400E-01 |
| Stage3-vs-Stage4 |
8.832600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.720400E-01 |
| Normal-vs-AfricanAmerican |
1.809370E-01 |
| Normal-vs-Asian |
7.961800E-02 |
| Caucasian-vs-AfricanAmerican |
3.535800E-01 |
| Caucasian-vs-Asian |
6.123900E-02 |
| AfricanAmerican-vs-Asian |
1.597440E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.401400E-01 |
| Normal-vs-Female |
4.567600E-01 |
| Male-vs-Female |
9.563200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.140400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.939600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.719800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.660700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.009600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.428400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.894420E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.671000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.783600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.358400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.634840E-01 |
| Normal-vs-Grade 2 |
9.413800E-01 |
| Normal-vs-Grade 3 |
1.034410E-01 |
| Normal-vs-Grade 4 |
5.000000E-01 |
| Grade 1-vs-Grade 2 |
2.628000E-01 |
| Grade 1-vs-Grade 3 |
6.122500E-02 |
| Grade 1-vs-Grade 4 |
1.931550E-01 |
| Grade 2-vs-Grade 3 |
4.366100E-02 |
| Grade 2-vs-Grade 4 |
4.006800E-01 |
| Grade 3-vs-Grade 4 |
5.811800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.577600E-01 |
| Normal-vs-ccB subtype |
7.571600E-01 |
| ccA subtype-vs-ccB subtype |
4.102600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.866400E-01 |
| Normal-vs-N1 |
4.385400E-01 |
| N0-vs-N1 |
3.619400E-01 |
|
|
